Abstract
Objective: Prosody, an important aspect of spoken language, is defined as the emphasis placed on certain syllables, changes in tempo or timing, and variance in pitch and intonation. Most studies investigating expression and comprehension of prosody have focused primarily on emotional prosody and less extensively on supralexical prosody. The distinction is indeed important, as the latter conveys information such as interrogative or assertive mode, whereas the former delivers emotional connotation, such as happiness, anger, and sadness. These functions appear to rely on distinct neuronal networks, supported by functional neuroimaging studies that show activation of the right hemisphere, specifically in the right inferior frontal area during emotional detection.
Conclusion: This review summarizes the studies conducted on prosody impairment in Alzheimer's disease and other dementias, with emphasis on experiments designed to investigate the emotional vs. the supralexical aspect of speech production. We also discussed the available tools validated to test and quantify the prosodic impairment.
Keywords: Alzheimer's disease, dementia, frontotemporal dementia, language, mild cognitive impairment, prosody.
Current Alzheimer Research
Title:Prosodic Impairment in Dementia: Review of the Literature
Volume: 15 Issue: 2
Author(s): Sylwia Misiewicz , Adam M. Brickman and Giuseppe Tosto *
Affiliation:
- G.H. Sergievsky Center, Department of Neurology, College of Physicians and Surgeons, Columbia University, New York, NY,United States
Keywords: Alzheimer's disease, dementia, frontotemporal dementia, language, mild cognitive impairment, prosody.
Abstract: Objective: Prosody, an important aspect of spoken language, is defined as the emphasis placed on certain syllables, changes in tempo or timing, and variance in pitch and intonation. Most studies investigating expression and comprehension of prosody have focused primarily on emotional prosody and less extensively on supralexical prosody. The distinction is indeed important, as the latter conveys information such as interrogative or assertive mode, whereas the former delivers emotional connotation, such as happiness, anger, and sadness. These functions appear to rely on distinct neuronal networks, supported by functional neuroimaging studies that show activation of the right hemisphere, specifically in the right inferior frontal area during emotional detection.
Conclusion: This review summarizes the studies conducted on prosody impairment in Alzheimer's disease and other dementias, with emphasis on experiments designed to investigate the emotional vs. the supralexical aspect of speech production. We also discussed the available tools validated to test and quantify the prosodic impairment.
Export Options
About this article
Cite this article as:
Misiewicz Sylwia , Brickman M. Adam and Tosto Giuseppe *, Prosodic Impairment in Dementia: Review of the Literature, Current Alzheimer Research 2018; 15 (2) . https://dx.doi.org/10.2174/1567205014666171030115624
DOI https://dx.doi.org/10.2174/1567205014666171030115624 |
Print ISSN 1567-2050 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5828 |
Call for Papers in Thematic Issues
New Advances in the Prevention, Diagnosis, Treatment, and Rehabilitation of Alzheimer's Disease
Aims and Scope: Introduction: Alzheimer's disease (AD) poses a significant global health challenge, with an increasing prevalence that demands concerted efforts to advance our understanding and strategies for prevention, diagnosis, treatment, and rehabilitation. This thematic issue aims to bring together cutting-edge research and innovative approaches from multidisciplinary perspectives to address ...read more
Current updates on the Role of Neuroinflammation in Neurodegenerative Disorders
Neuroinflammation is an invariable hallmark of chronic and acute neurodegenerative disorders and has long been considered a potential drug target for Alzheimer?s disease (AD) and dementia. Significant evidence of inflammatory processes as a feature of AD is provided by the presence of inflammatory markers in plasma, CSF and postmortem brain ...read more
Deep Learning for Advancing Alzheimer's Disease Research
Alzheimer's disease (AD) poses a significant global health challenge, with an increasing number of individuals affected yearly. Deep learning, a subfield of artificial intelligence, has shown immense potential in various domains, including healthcare. This thematic issue of Current Alzheimer Research explores the application of deep learning techniques in advancing our ...read more
Diagnostic and therapeutic biomarkers of dementia
Dementia affects 18 million people worldwide. Dementia is a syndrome of symptoms caused by brain disease, usually chronic or progressive, clinically characterized by multiple impairments of higher cortical functions such as memory, thinking, orientation, and learning. In addition, in the course of dementia, cognitive deficits are observed, which often hinder ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Gene-Gene and Gene-Environment Interaction on the Risk of Parkinson’s Disease
Current Aging Science Towards More Efficient Glutathione Peroxidase Mimics: Substrate Recognition and Catalytic Group Assembly
Current Medicinal Chemistry Microglial dependent protective effects of neuroactive steroids
CNS & Neurological Disorders - Drug Targets Pharmacogenetic Aspects of Therapy with Cholinesterase Inhibitors: The Role of CYP2D6 in Alzheimers Disease Pharmacogenetics
Current Alzheimer Research Inflammatory Biomarkers, Depressive Symptoms and Falls Among the elderly in Panama
Current Aging Science Amyloid-β Immunotherapy for Alzheimers Disease
CNS & Neurological Disorders - Drug Targets Aberrant Neuronal Activity and Dysfunctional Connectivity in Aβ<sub>1–42</sub>- mediated Memory Deficits in Rats
Current Alzheimer Research The Potential Therapeutic Role of the HMGB1-TLR Pathway in Epilepsy
Current Drug Targets Multiple Roles for Chemokines in the Pathogenesis of SIV Infection
Current HIV Research Membrane Damage Induced by Amyloid Beta and a Potential Link with Neuroinflammation
Current Pharmaceutical Design Traumatic Brain Injury and Blood-Brain Barrier Cross-Talk
CNS & Neurological Disorders - Drug Targets MicroRNA Expression Analysis of Adult-Onset Drosophila Alzheimer`s Disease Model
Current Alzheimer Research Effects of Antiplatelet Medication on Arteriovenous Fistula Patency After Surgical Thrombectomy
Current Vascular Pharmacology Lipid Rafts Mediate Amyloid-Induced Calcium Dyshomeostasis and Oxidative Stress in Alzheimer’s Disease
Current Alzheimer Research Na+-H+ Exchanger, pH Regulation and Cancer
Recent Patents on Anti-Cancer Drug Discovery Anticholinesterase and Antioxidant Activities of Natural Abietane Diterpenoids with Molecular Docking Studies
Current Alzheimer Research Editorial [Celebrating the Fifth Year Anniversary of Current Alzheimer Research(Guest Editor: Debomoy K. Lahiri)]
Current Alzheimer Research Neurotrophin Receptor Signaling as a Therapeutic Target for Huntington's Disease
CNS & Neurological Disorders - Drug Targets A Prospective Study for Introducing Insulin Pens and Safety Needles in a Hospital Setting. The SANITHY Study
Current Diabetes Reviews Subject Index To Volume 3
Vascular Disease Prevention (Discontinued)